SCHEMBL30740794

SCHEMBL30740794

CC(C)(C)OC(=O)N1CCCCC1Oc1ccnc(COc2ccc(Cl)cc2CF)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.40
▸ MEN1 O00255 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ PTGER1 P34995 8/20 0.36
▸ HTR2C P28335 2/20 0.36
▸ SLC6A4 P31645 2/20 0.36
▸ AHCY P23526 1/20 0.36
▸ ANO1 Q5XXA6 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ EPHA2 P29317 1/20 0.35
▸ KDR P35968 1/20 0.35
▸ EPHB4 P54760 1/20 0.35
▸ HTR2B P41595 1/20 0.35
▸ GRM5 P41594 1/20 0.34
▸ OPRK1 P41145 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30740733 0.93 ALDH1A1 (0.41) ALDH1A1MEN1LMNAMAPTTSHR
SCHEMBL30740746 0.87 ALDH1A1 (0.40) ALDH1A1MEN1LMNAMAPTTSHR
SCHEMBL29826118 0.86 CACNB4 (0.44) CYP2C9
SCHEMBL30740829 0.85 LMNA (0.46) ALDH1A1MEN1LMNAKMT2AEPHA2
SCHEMBL30745378 0.81 SCN9A (0.39) ALDH1A1GRM5
SCHEMBL30740755 0.80 LNPEP (0.38) ALDH1A1LMNANPSR1OPRK1
SCHEMBL30740827 0.79 GPR119 (0.38) —
SCHEMBL29826391 0.79 CACNB4 (0.44) CYP2C9
SCHEMBL29826215 0.76 CYP2C9 (0.44) TSHRCYP2C9
SCHEMBL27477980 0.75 USP30 (0.38) ALDH1A1HTR2CSLC6A4HTR2BGRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117043154-A GPCR receptor agonists, pharmaceutical compositions comprising same, and methods of use thereof 卡莫特医疗有限公司 2023-11-10 — — CN disclosed
Send feedback